RESUMO
INTRODUCTION: Alternaria alternata is a widespread fungi whose allergy is a risk factor for asthma development. The use of a polymerized allergen extract (allergoid) may be safer than native extract based treatments while maintaining efficacy. The objective of this study was to characterize biochemically and immunochemically a new Alternaria alternata allergoid. METHODS: Characterization of native and allergoid extracts was performed by determination of protein content, protein and allergenic profile, biological potency, identification of Alternaria allergens, and Alt a 1 quantification. Safety was evaluated in toxicological assays (Ames test, limit test, and fish embryo acute toxicity test in zebrafish, and maximum tolerated dose and Dose-range finding study in rats). Efficacy was evaluated as the capacity to induce IgG antibodies that block IgE-binding to the allergen and cytokine induction (IFN-γ, IL-4, IL-6, IL-10, and TNF-α) in PBMC from atopic donors. RESULTS: Protein and antigenic profiles showed significant modification of the depigmented allergoid with respect to the native extract, inducing a lower IgE binding capacity. Alt a 1, Alt a 3, Alt a 6, and Alt a 8 allergen sequences were identified in the polymer. No toxicological nor genotoxicity effects were observed. The polymer induced IgG antibodies that blocked human IgE binding epitopes, and it induced higher IL-10 levels and similar levels of the other cytokines than native extract in PBMC. CONCLUSIONS: This new A. alternata allergoid could be an effective immunotherapy treatment leading to cytokine stimulation and inducing synthesis of IgG antibodies able to block IgE binding to the allergen. In addition, no toxicological effect was observed, and it may be safer than native extract due to its lower IgE binding capacity and cytokine induction that suggest tolerance induction via T cell shift to Treg (IL-10).
Assuntos
Alternaria/imunologia , Anticorpos Antifúngicos/imunologia , Asma/terapia , Imunoterapia/métodos , Extratos Vegetais/imunologia , Alérgenos/química , Alérgenos/imunologia , Alérgenos/uso terapêutico , Alérgenos/toxicidade , Alergoides , Animais , Anticorpos Antifúngicos/sangue , Especificidade de Anticorpos , Antígenos de Fungos/administração & dosagem , Antígenos de Fungos/química , Antígenos de Fungos/imunologia , Antígenos de Fungos/toxicidade , Asma/imunologia , Bioensaio/métodos , Citocinas/imunologia , Citocinas/metabolismo , Avaliação Pré-Clínica de Medicamentos , Embrião não Mamífero , Feminino , Cobaias , Humanos , Imunoglobulina E/sangue , Imunoglobulina E/imunologia , Imunoglobulina G/sangue , Imunoglobulina G/imunologia , Interleucina-10/imunologia , Interleucina-10/metabolismo , Leucócitos Mononucleares , Masculino , Camundongos , Extratos Vegetais/administração & dosagem , Extratos Vegetais/química , Extratos Vegetais/toxicidade , Polímeros/administração & dosagem , Polímeros/química , Polímeros/toxicidade , Ratos , Ratos Sprague-Dawley , Linfócitos T Reguladores/imunologia , Linfócitos T Reguladores/metabolismo , Testes de Toxicidade/métodos , Peixe-ZebraRESUMO
Paracoccidioidomycosis is a systemic granulomatous disease caused by the dimorphic fungus Paracoccidioides brasiliensis. Its major antigen is a 43 kDa glycoprotein whose peptides embody different functions: P10 peptide, a T-cell epitope, induces protective response while P4 and P23 peptides inhibit both, macrophage functions and inflammatory reaction, thus facilitating infection. Here we investigated the modulating mechanisms of the immune response exerted by P4 and P23 involved in the latter inhibitory effect on macrophages. Moreover we analyzed the peptides effects in different models in vivo. While evaluating whether P4 and P23 present systemic anti-inflammatory effects in vivo, we showed that their intraperitonial administration decreased footpad swelling in mice infected with either P. brasiliensis or Mycobacterium bovis. Both, qPCR and ELISA assays suggested that this anti-inflammatory effect depended on alterations in the kinetics of production of innate immunity modulators such as TNF-α, IL6, IL10 and TLR2. IL10 seems to be early produced than TNF-α and IL6, produced later in presence of peptides. Higher doses or intravenously given P4 and P23 resulted in earlier and more prolonged anti-inflammatory effects. Moreover, continuous treatment with P4 and P23 sustained the anti-inflammatory activity throughout.
Assuntos
Anti-Inflamatórios/uso terapêutico , Antígenos de Fungos/química , Proteínas Fúngicas/química , Glicoproteínas/química , Inflamação/tratamento farmacológico , Paracoccidioides/patogenicidade , Paracoccidioidomicose/tratamento farmacológico , Peptídeos/uso terapêutico , Sequência de Aminoácidos , Animais , Anti-Inflamatórios/farmacologia , Citocinas/imunologia , Citocinas/metabolismo , Pé/microbiologia , Inflamação/imunologia , Inflamação/microbiologia , Macrófagos/efeitos dos fármacos , Macrófagos/imunologia , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Dados de Sequência Molecular , Paracoccidioides/efeitos dos fármacos , Paracoccidioidomicose/imunologia , Paracoccidioidomicose/microbiologia , Paracoccidioidomicose/fisiopatologia , Peptídeos/síntese química , Peptídeos/química , Peptídeos/farmacologiaRESUMO
Chemotherapy is the basis of treatment of paracoccidioidomycosis in its various forms. Depending on the Paracoccidioides brasiliensis virulence, the status of host immunity, the degree of tissue involvement and fungal dissemination, treatment can be extended for long periods with an alarming frequency of relapses. Association of chemotherapy with a vaccine to boost the cellular immune response seemed a relevant project not only to reduce the time of treatment but also to prevent relapses and improve the prognosis of anergic cases. The candidate immunogen is the gp43 major diagnostic antigen of P. brasiliensis and more specifically its derived peptide P10, carrying the CD4+ T-cell epitope. Both gp43 and P10 protected Balb/c mice against intratracheal infections with virulent P. brasiliensis strain. P10 as single peptide or in a multiple-antigen-peptide (MAP) tetravalent construction was protective without adjuvant either by preimmunization and intratracheal challenge or as a therapeutic agent in mice with installed infection. P10 showed additive protective effects in drug-treated mice stimulating a Th-1 type immune response with high IFN-gamma and IL-12. P10 and few other peptides in the gp43 were selected by Tepitope algorithm and actually shown to promiscuously bind several prominent HLA-DR molecules suggesting that a peptide vaccine could be devised for a genetically heterogenous population. P10 was protective in animals turned anergic, was effective in a DNA minigene vaccine, and increased the protection by monoclonal antibodies in Balb/c mice. DNA vaccines and peptide vaccines are promising therapeutic tools to be explored in the control of systemic mycoses.
Assuntos
Adjuvantes Imunológicos/uso terapêutico , Antifúngicos/uso terapêutico , Antígenos de Fungos/imunologia , Proteínas Fúngicas/imunologia , Vacinas Fúngicas , Glicoproteínas/imunologia , Paracoccidioides/imunologia , Paracoccidioidomicose/prevenção & controle , Peptídeos , Sequência de Aminoácidos , Animais , Antígenos de Fungos/química , Terapia Combinada , Proteínas Fúngicas/química , Vacinas Fúngicas/administração & dosagem , Vacinas Fúngicas/síntese química , Vacinas Fúngicas/química , Vacinas Fúngicas/imunologia , Glicoproteínas/química , Humanos , Camundongos , Camundongos Endogâmicos BALB C , Dados de Sequência Molecular , Paracoccidioidomicose/microbiologia , Peptídeos/administração & dosagem , Peptídeos/síntese química , Peptídeos/química , Peptídeos/imunologia , Resultado do Tratamento , VacinaçãoRESUMO
The protective role of specific antibodies against Paracoccidioides brasiliensis is controversial. In the present study, we analyzed the effects of monoclonal antibodies on the major diagnostic antigen (gp43) using in vitro and in vivo P. brasiliensis infection models. The passive administration of some monoclonal antibodies (MAbs) before and after intratracheal or intravenous infections led to a reduced fungal burden and decreased pulmonary inflammation. The protection mediated by MAb 3E, the most efficient MAb in the reduction of fungal burden, was associated with the enhanced phagocytosis of P. brasiliensis yeast cells by J774.16, MH-S, or primary macrophages. The ingestion of opsonized yeast cells led to an increase in NO production by macrophages. Passive immunization with MAb 3E induced enhanced levels of gamma interferon in the lungs of infected mice. The reactivity of MAb 3E against a panel of gp43-derived peptides suggested that the sequence NHVRIPIGWAV contains the binding epitope. The present work shows that some but not all MAbs against gp43 can reduce the fungal burden and identifies a new peptide candidate for vaccine development.
Assuntos
Anticorpos Monoclonais/uso terapêutico , Antígenos de Fungos/imunologia , Proteínas Fúngicas/imunologia , Glicoproteínas/imunologia , Paracoccidioides/patogenicidade , Paracoccidioidomicose/imunologia , Paracoccidioidomicose/prevenção & controle , Traqueia/microbiologia , Sequência de Aminoácidos , Animais , Anticorpos Monoclonais/imunologia , Antígenos de Fungos/química , Linhagem Celular , Células Cultivadas , Epitopos/química , Proteínas Fúngicas/química , Glicoproteínas/química , Imunização Passiva , Injeções Intravenosas , Macrófagos Alveolares/microbiologia , Macrófagos Peritoneais/microbiologia , Camundongos , Camundongos Endogâmicos BALB C , Dados de Sequência Molecular , Paracoccidioides/imunologia , Paracoccidioidomicose/diagnóstico , Paracoccidioidomicose/parasitologia , Fagocitose , Resultado do TratamentoRESUMO
Autophagy is the major cellular pathway for bulk degradation of cytosolic material and is required to maintain viability under starvation conditions. To determine the contribution of autophagy to starvation stress responses in the filamentous fungus Aspergillus fumigatus, we disrupted the A. fumigatus atg1 gene, encoding a serine/threonine kinase required for autophagy. The DeltaAfatg1 mutant showed abnormal conidiophore development and reduced conidiation, but the defect could be bypassed by increasing the nitrogen content of the medium. When transferred to starvation medium, wild-type hyphae were able to undergo a limited amount of growth, resulting in radial expansion of the colony. In contrast, the DeltaAfatg1 mutant was unable to grow under these conditions. However, supplementation of the medium with metal ions rescued the ability of the DeltaAfatg1 mutant to grow in the absence of a carbon or nitrogen source. Depleting the medium of cations by using EDTA was sufficient to induce autophagy in wild-type A. fumigatus, even in the presence of abundant carbon and nitrogen, and the DeltaAfatg1 mutant was severely growth impaired under these conditions. These findings establish a role for autophagy in the recycling of internal nitrogen sources to support conidiophore development and suggest that autophagy also contributes to the recycling of essential metal ions to sustain hyphal growth when exogenous nutrients are scarce.
Assuntos
Antígenos de Fungos/química , Aspergillus fumigatus/genética , Aspergillus fumigatus/metabolismo , Autofagia , Íons/química , Metais/química , Proteínas Quinases/fisiologia , Proteínas de Saccharomyces cerevisiae/fisiologia , Animais , Proteínas Relacionadas à Autofagia , Cátions , Ácido Edético/química , Camundongos , Camundongos Endogâmicos C57BL , Modelos Biológicos , Nitrogênio/química , Oligonucleotídeos/química , Proteínas Quinases/genética , Proteínas de Saccharomyces cerevisiae/genética , Especificidade da EspécieRESUMO
Antibodies to the glucuronoxylomannan (GXM) component of the polysaccharide capsule of Cryptococcus neoformans are protective and GXM-protein conjugate vaccines can elicit protective immune responses. We report the synthesis of a heptasaccharide oligosaccharide representing the putative dominant motif of serotype A GXM and demonstrate that it is recognized by some monoclonal antibodies (mAbs) generated to GXM. Conjugation of the heptasaccharide to human serum albumin (HSA) resulted in an immunogenic compound that elicited high-titer IgG responses in mice when given with complete Freund's adjuvant. The antibody response elicited by the oligosaccharide conjugate vaccine had characteristics of a T-cell-dependent response. The availability of an immunogenic oligosaccharide representing a structural motif of GXM will prove useful in studies of antibody epitope specificity and represents a potential synthetic oligosaccharide vaccine against this fungal pathogen.
Assuntos
Antígenos de Fungos/química , Antígenos de Fungos/imunologia , Cryptococcus neoformans/imunologia , Vacinas Fúngicas/síntese química , Vacinas Fúngicas/imunologia , Polissacarídeos/síntese química , Polissacarídeos/imunologia , Animais , Anticorpos Monoclonais/química , Anticorpos Monoclonais/imunologia , Biotina , Sequência de Carboidratos , Cromatografia em Camada Fina , Ensaio de Imunoadsorção Enzimática , Imunofluorescência , Humanos , Esquemas de Imunização , Indicadores e Reagentes , Espectroscopia de Ressonância Magnética , Camundongos , Camundongos Endogâmicos BALB C , Dados de Sequência Molecular , Albumina Sérica/químicaRESUMO
Historically, the therapy of serious fungal infection has been dominated by monotherapy with the polyene antibiotic amphotericin B. Clinical failures, side effects, the lack of alternatives and the toxicity of this drug have heightened the need to produce alternative therapies, which have included fluconazole, voriconazole and caspofungin. The observation that recovery from disseminated candidiasis was associated with an antibody response to the 47 kDa Candida heat-shock protein (HSP)90 homologue, coupled with the ability to sequence all the antibodies from patients who have recovered from the infection and to re-express the dominant ones as fragments in Escherichia coli, has opened the possibility of immunotherapy. The first recombinant antibody fragment, Mycograb (Neu Tec Pharma plc), against Candida HSP90 is now in clinical trials in patients with disseminated candidiasis in Europe and the US. Laboratory and early clinical data support the concept of synergy between Mycograb and amphotericin B. This should improve outcome and diminish the risk of resistance occurring to either drug, without an increase in toxicity, as this should be minimal in a human antibody fragment representing the natural antibody that a patient produces on recovery.
Assuntos
Anticorpos Antifúngicos/genética , Anticorpos Antifúngicos/uso terapêutico , Candidíase/terapia , Animais , Antígenos de Fungos/química , Antígenos de Fungos/imunologia , Epitopos/genética , Epitopos/imunologia , Proteínas de Choque Térmico HSP90/genética , Proteínas de Choque Térmico HSP90/uso terapêutico , Humanos , Proteínas Recombinantes/genética , Proteínas Recombinantes/uso terapêuticoRESUMO
Aspergillus fumigatus, a ubiquitous fungus, is implicated in the pathogenesis of a number of clinically different allergic diseases in man, including allergic bronchopulmonary aspergillosis. Peptide-based immunotherapy may offer an alternative treatment strategy for the management of allergic disease. The objective of this study was to alter the allergen-specific immune response using dominant T cell epitopes of a major A. fumigatus allergen, Asp f2, expressed in yeast as virus-like particles (VLP). The T cell epitopes of Asp f2, recognized in mice with an H-2d background, were determined by producing T-cell hybridomas. Two dominant T cell epitopes, aa60--71 and aa235--249, were identified and expressed in a yeast VLP system. To induce tolerance VLP-peptides were injected subcutaneously into mice previously immunized with recombinant Asp f2. The T cell immune response was abrogated totally in 3 weeks following a single injection of VLP but was restored 2 months later following intranasal antigen exposure. T-cell depletion resulted in the reduction of 20-30% of all antigen-specific immunoglobulin classes. Thus, recombinant peptides expressed in the VLP system can be used successfully in the modulation of Asp f2-induced immune response in mice, although a single administration is not sufficient to maintain a state of tolerance for a long period of time.
Assuntos
Alérgenos/uso terapêutico , Antígenos de Fungos/uso terapêutico , Aspergilose/terapia , Aspergillus fumigatus/imunologia , Dessensibilização Imunológica , Proteínas Fúngicas/uso terapêutico , Epitopos Imunodominantes/imunologia , Peptídeos/uso terapêutico , Linfócitos T/imunologia , Alérgenos/efeitos adversos , Alérgenos/química , Alérgenos/imunologia , Sequência de Aminoácidos , Animais , Antígenos de Fungos/efeitos adversos , Antígenos de Fungos/química , Antígenos de Fungos/imunologia , Aspergilose/etiologia , Aspergilose/imunologia , Células Cultivadas/imunologia , Ensaio de Imunoadsorção Enzimática , Proteínas Fúngicas/efeitos adversos , Proteínas Fúngicas/química , Proteínas Fúngicas/imunologia , Hibridomas/imunologia , Imunização , Interleucina-2/biossíntese , Linfonodos/citologia , Linfonodos/imunologia , Camundongos , Camundongos Endogâmicos BALB C , Dados de Sequência Molecular , Peptídeos/química , Peptídeos/imunologia , Proteínas Recombinantes de Fusão/química , Proteínas Recombinantes de Fusão/imunologia , Proteínas Recombinantes de Fusão/uso terapêutico , Baço/citologia , Baço/imunologiaRESUMO
A glycoprotein with an apparent molecular weight of 93 kDa was purified from a water-soluble extract of Aspergillus fumigatus NCPF 2109 by single step affinity chromatography using the mannose-specific snowdrop (Galanthus nivalis) lectin coupled to agarose. The carbohydrate moiety contained only mannose and galactose. Partial sequencing of cyanogen bromide fragments of the antigen yielded two sequences, KQNKP and GEIPMKF?PQL, with no homology to any reported proteins. In a preliminary evaluation of its diagnostic potential the 93 kDa antigen was recognized by the sera of four patients with allergic bronchopulmonary aspergillosis, in addition to a monoclonal antibody raised against a partially purified fraction of the A. fumigatus water-soluble extract.
Assuntos
Anticorpos Antifúngicos/sangue , Antígenos de Fungos/isolamento & purificação , Aspergilose Broncopulmonar Alérgica/diagnóstico , Aspergillus fumigatus/imunologia , Sequência de Aminoácidos , Anticorpos Monoclonais , Antígenos de Fungos/química , Aspergilose Broncopulmonar Alérgica/sangue , Aspergilose Broncopulmonar Alérgica/imunologia , Aspergillus fumigatus/isolamento & purificação , Cromatografia de Afinidade , Cromatografia em Gel , Eletroforese em Gel de Poliacrilamida , Galanthus , Humanos , Lectinas , Peso Molecular , Lectinas de PlantasRESUMO
Neurospora crassa NAD(P)H-nitrite reductase, encoded by the nit-6 gene, is a soluble, alpha2-type homodimeric protein composed of 127-kDa polypeptide subunits. This multicenter oxidation-reduction enzyme utilizes either NADH or NADPH as electron donor and possesses as prosthetic groups two iron-sulfur (Fe4S4) clusters, two siroheme groups, and two FAD molecules. The native activity of the enzyme is the NAD(P)H-dependent reduction of nitrite to ammonia. In addition, N. crassa nitrite reductase displays several partial activities in vitro, including a siroheme-independent NAD(P)H-cytochrome c reductase activity and an FAD-independent dithionite-nitrite reductase activity. These partial activities are presumed to be manifestations of discrete functional domains within the protein. A full-length nit-6 cDNA was constructed and used in developing an expression system within E. coli capable of yielding high levels of NADPH-nitrite reductase activity. Maximal expression was obtained in nirB- E. coli cells grown anaerobically at 22 +/- 1 degrees C, in conjunction with co-expression of a plasmid-borne cysG gene (encoding the rate-limiting enzyme in siroheme synthesis) and co-transformation with plasmid pGroESL (encoding bacterial chaperonins GroES and GroEL). Dissection of gene segments encoding putative functional domains within the nit-6 gene was performed. Expression of a partial cDNA construct encoding the FAD-/NAD-binding domain yielded extracts with NADPH-cytochrome c reductase activity but no NADPH-nitrite reductase activity or dithionite-nitrite reductase activity. Expression of a cDNA construct encoding the (Fe4S4)-siroheme-binding domain resulted in extracts possessing dithionite-nitrite reductase activity but no NADPH-nitrite reductase or NADPH-cytochrome c reductase activity. Analysis of site-directed mutations altering amino acid residues Cys-331 within the FAD-/NAD-binding domain and Ser-755 within the (Fe4S4)-siroheme-binding domain of the nitrite reductase demonstrated that these residues were not essential for native or partial enzyme activity. Cys-757 within the (Fe4S4)-siroheme-binding domain was essential for native enzyme activity.
Assuntos
Neurospora crassa/enzimologia , Nitrito Redutases/química , Sequência de Aminoácidos , Antígenos de Fungos/química , Sítios de Ligação , Western Blotting , DNA Complementar/genética , Flavina-Adenina Dinucleotídeo/metabolismo , Proteínas Fúngicas/química , Proteínas Fúngicas/genética , Proteínas Fúngicas/metabolismo , Genes Fúngicos , Heme/análogos & derivados , Heme/metabolismo , Dados de Sequência Molecular , Mutagênese Sítio-Dirigida , NAD/metabolismo , Neurospora crassa/genética , Nitrito Redutase (NAD(P)H) , Nitrito Redutases/genética , Nitrito Redutases/metabolismo , RNA Fúngico/genética , RNA Mensageiro/genética , Proteínas Recombinantes , Relação Estrutura-AtividadeRESUMO
cDNA sequences encoding a cell wall protein have been isolated from the opportunistic pathogen, Candida albicans, an organism that can cause serious disease in immunocompromised patients such as those with AIDS. The cDNA encodes a peptide that is largely composed of an acidic, repeated motif 10 amino acids in length that is rich in proline and glutamine residues. The cDNA gene product was found to be present on hyphal surfaces by immunofluorescence assays using monospecific antisera raised to the recombinant protein produced in Pichia pastoris. The hyphae-specific surface location was also seen on organisms colonizing the gastrointestinal mucosa of mice, indicating that the antigen is produced and developmentally regulated during growth in host tissues. The cDNA clone hybridized to an abundant messenger RNA 2.3 kilobases in size that was present in hyphal but not yeast forms. These studies demonstrate that the bud-hypha transition is accompanied by the de novo synthesis of proteins that are targeted to hyphal surfaces. The primary sequence of the unique amino acid motif shares features with surface proteins of other lower eukaryotic microorganisms and with host acidic salivary proline-rich proteins.